Sonoma Pharmaceuticals (SNOA) Short term Debt (2011 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Short term Debt of $56000.0 in Q3 2025, down 59.71% quarter-over-quarter from $139000.0 in Q2 2025, and down 31.71% on a YoY basis from $82000.0 in Q3 2024.
Sonoma Pharmaceuticals (SNOA) Short term Debt (2011 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Short term Debt history runs 15 years deep, the most recent figure standing at $56000.0 for Q3 2025.
- In Q3 2025, Short term Debt fell 31.71% year-over-year to $56000.0; the TTM figure through Sep 2025 stood at $56000.0 (down 31.71% YoY), while the FY2025 annual figure was $220000.0, down 31.89% from the prior year.
- Short term Debt was $56000.0 for Q3 2025 at Sonoma Pharmaceuticals, down from $139000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $688000.0 in Q1 2022 to a low of $44000.0 in Q4 2023.
- Historically, Short term Debt has averaged $283750.0 across 5 years, with a median of $224500.0 in 2022.
- The sharpest annual moves came in 2021 and 2024: Short term Debt jumped 306.12% in 2021, then slumped 52.33% in 2024.
- A 5-year view of Short term Debt shows it stood at $199000.0 in 2021, then gained by 15.08% to $229000.0 in 2022, then plunged by 80.79% to $44000.0 in 2023, then surged by 86.36% to $82000.0 in 2024, then plunged by 31.71% to $56000.0 in 2025.
- The last three Short term Debt figures came in at $56000.0 (Q3 2025), $139000.0 (Q2 2025), and $220000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 204,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 431,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Mar 31, 2022 | 688,000.00 |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 397,000.00 |
| Mar 31, 2021 | 596,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | 265,000.00 |
| Mar 31, 2020 | 481,000.00 |
| Sep 30, 2019 | 106,000.00 |